{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T21:06:14Z","timestamp":1792357574117,"version":"4.4.0"},"reference-count":23,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anti-M is a frequently detected naturally occurring antibody that has been reported in various clinical settings and also in voluntary donors. We describe here the clinical and laboratory findings of 11 cases with anti-M detected at our center. This report is a retrospective study in which we reviewed our immunohematology laboratory records for cases involving anti-M. Both donor and patient data from a 28-month period (September 2014 to December 2016) were reviewed. During this period, 11 examples of anti-M were detected (8 patients, 1 voluntary whole blood donor, and 1 hematopoietic stem cell donor. Anti-M was also detected in one external quality assessment scheme sample received during this period. In conclusion, anti-M can be detected in various clinical settings. This antibody can be clinically significant; in the laboratory, it can present as a serologic problem such as an ABO group discrepancy or an incompatible crossmatch. After detection, management and course of action is determined by both the antibody characteristics and the clinical setting.\n                    <jats:italic>\n                      <jats:bold>Immunohematology<\/jats:bold>\n                    <\/jats:italic>\n                    <jats:bold>2017;33:165\u2013169.<\/jats:bold>\n                  <\/jats:p>","DOI":"10.21307\/immunohematology-2019-024","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T18:01:34Z","timestamp":1619805694000},"page":"165-169","source":"Crossref","is-referenced-by-count":6,"title":["Clinical and laboratory profile of anti-M"],"prefix":"10.2478","volume":"33","author":[{"given":"D.","family":"Basu","sequence":"first","affiliation":[{"name":"Transfusion Medicine , Tata Medical Center , 14 Middle Arterial Road (EW) , Rajarhat, New Town, Kolkata , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Basu","sequence":"additional","affiliation":[{"name":"Department , Transfusion Medicine ; Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Transfusion Medicine ; Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Transfusion Medicine ; Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chandy","sequence":"additional","affiliation":[{"name":"Department , Clinical Haematology , Tata Medical Center , Kolkata , India ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"2026052521502524045_j_immunohematology-2019-024_ref_001","doi-asserted-by":"crossref","unstructured":"Landsteiner K, Levine P. On individual differences in human blood. J Exp Med 1928;47:757\u20137.10.1084\/jem.47.5.757213139919869442","DOI":"10.1084\/jem.47.5.757"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_002","doi-asserted-by":"crossref","unstructured":"Wolff E, Johnson B. Studien uber die untergruppen A1 and A2 mit besonderer berucksichtigung der paternitatsuntersuchungen. Dtsch Ztschr Gerichtl Med 1933;22:65\u201385.10.1007\/BF01756867","DOI":"10.1007\/BF01756867"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_003","unstructured":"Fung KM, Eder AF, Spitalnik S, Westhoff CM, Eds. Technical manual. 19th ed. Bethesda, MD: AABB, 2017:323\u20136."},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_004","doi-asserted-by":"crossref","unstructured":"Southcott MJ, Tanner MJ, Anstee DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999;93:4425\u201335.10.1182\/blood.V93.12.4425","DOI":"10.1182\/blood.V93.12.4425.412k22_4425_4435"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_005","unstructured":"Makroo RN, Bhatia A, Gupta R, et al. Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population. Indian J Med Res 2013;137:521\u20136."},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_006","doi-asserted-by":"crossref","unstructured":"Klein HG, Anstee DJ. Other red cell antigens. In: Klein HG, Anstee DJ, Eds. Mollison\u2019s blood transfusion in clinical medicine. 11th ed. London: Blackwell Science, 2005;209\u201352.","DOI":"10.1002\/9780470986868"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_007","doi-asserted-by":"crossref","unstructured":"Daniels G. Human blood groups. 3rd ed. Oxford: Blackwell Scientific Publications, 2002:94\u2013161.10.1002\/9780470987018","DOI":"10.1002\/9780470987018"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_008","unstructured":"Fung KM, Eder AF, Spitalnik S, Westhoff CM, Eds. Technical manual. 19th ed. Bethesda, MD: AABB, 2017: Method 3-15."},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_009","doi-asserted-by":"crossref","unstructured":"Bhangale A, Pathak A, Pawar S, Jeloka T. Comparison of antibody titers using conventional tube technique versus column agglutination technique in ABO blood group incompatible renal transplant. Asian J Transfus Sci 2017;11:131\u20134.10.4103\/0973-6247.214343561341928970680","DOI":"10.4103\/0973-6247.214343"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_010","unstructured":"Das R, Dubey A, Agarwal P, Chaudhry RK. Spectrum of anti-M: a report of three unusual cases. Blood Transfus 2014;12:99\u2013102."},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_011","unstructured":"Mathur A, Dontula S, Jagannathan L. An unusual case of potentially clinically significant anti-M antibody in a healthy male blood donor without any history of blood transfusion. Blood Transfus 2011;9:339."},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_012","unstructured":"Sacher RA, Abbondanzo SL, Miller DK, Womac B. Auto anti-M: clinical and serological findings of seven patients from one hospital and review of the literature. Am J Clin Pathol 1979;32:154\u20137."},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_013","doi-asserted-by":"crossref","unstructured":"Tandon R, Kataria R, Chaudhry R. Anti-M: report of two cases and review of literature. Asian J Transfus Sci 2008;2:81\u20133.10.4103\/0973-6247.42695279877220041082","DOI":"10.4103\/0973-6247.42695"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_014","doi-asserted-by":"crossref","unstructured":"Kaur G, Basu S, Kaur P, et al. Clinically significant anti-M antibodies: a report of two cases. Transfus Apher Sci 2012;47:259\u201361.10.1016\/j.transci.2012.07.02322980914","DOI":"10.1016\/j.transci.2012.07.023"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_015","doi-asserted-by":"crossref","unstructured":"Combs MR, O\u2019Rourke MM, Issitt PD, Telen MJ. An auto anti-M causing haemolysis in vitro. Transfusion 1991;31:756\u20138.10.1046\/j.1537-2995.1991.31892023504.x1926323","DOI":"10.1046\/j.1537-2995.1991.31892023504.x"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_016","doi-asserted-by":"crossref","unstructured":"Beattie KM, Zuelzer WW. The frequency and properties of pH-dependent anti-M. Transfusion 1965;4:322\u20136.","DOI":"10.1111\/j.1537-2995.1965.tb01180.x"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_017","doi-asserted-by":"crossref","unstructured":"Sancho JM, Pujol M, Fernandez F, et al. Delayed haemolytic transfusion reaction due to anti-M antibody. Br J Haematol 1998;103:268\u20139.10.1046\/j.1365-2141.1998.00970.x9792320","DOI":"10.1046\/j.1365-2141.1998.00970.x"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_018","doi-asserted-by":"crossref","unstructured":"Alperin JB, Riglin H, Branch DR, et al. Anti-M causing delayed hemolytic transfusion reaction. Transfusion 1983;23:322\u20134.10.1046\/j.1537-2995.1983.23483276867.x6879672","DOI":"10.1046\/j.1537-2995.1983.23483276867.x"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_019","doi-asserted-by":"crossref","unstructured":"Furlong MB, Monaghan WP. Delayed hemolytic episodes due to anti-M. Transfusion 1981;21:45\u20139.10.1046\/j.1537-2995.1981.21181127482.x7466906","DOI":"10.1046\/j.1537-2995.1981.21181127482.x"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_020","doi-asserted-by":"crossref","unstructured":"Wikman A, Edner A, Gryfelt G, et al. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization. Transfusion 2007;47:911\u20137.10.1111\/j.1537-2995.2007.01209.x17465958","DOI":"10.1111\/j.1537-2995.2007.01209.x"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_021","doi-asserted-by":"crossref","unstructured":"Thompson DJ, Stults DZ, Daniel SJ, et al. Anti-M antibody in pregnancy. Obstet Gynecol Surv 1989;44:637\u201341.10.1097\/00006254-198909000-000012771305","DOI":"10.1097\/00006254-198909000-00001"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_022","doi-asserted-by":"crossref","unstructured":"Arora S, Doda V, Maria A, et al. Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins. Asian J Transfus Sci 2015;9:98\u2013101.10.4103\/0973-6247.150968433994725722586","DOI":"10.4103\/0973-6247.150968"},{"key":"2026052521502524045_j_immunohematology-2019-024_ref_023","doi-asserted-by":"crossref","unstructured":"Hinchliffe RF, Nolan B, Vora AJ, et al. Neonatal pure red cell aplasia due to anti-M. Arch Dis Child Fetal Neonatal Ed 2006;9:F467\u20138.10.1136\/adc.2006.102954267278017056856","DOI":"10.1136\/adc.2006.102954"}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.21307\/immunohematology-2019-024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T21:50:42Z","timestamp":1779745842000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.21307\/immunohematology-2019-024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,10,16]]},"published-print":{"date-parts":[[2017,1,1]]}},"alternative-id":["10.21307\/immunohematology-2019-024"],"URL":"https:\/\/doi.org\/10.21307\/immunohematology-2019-024","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,1]]}}}